Brent A. Evans

机构：Georgia College & State University · ORCID：0000-0002-4590-3073

发表论文 73 篇 · 总被引 3049 次 · h-index 19

代表论文

• Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study (2022 · Annals of Oncology · 被引 154)
• Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk (2019 · JCO Precision Oncology · 被引 52)
• Evaluation of homologous recombination deficiency (HRD) status with pathological response to carboplatin +/- veliparib in BrighTNess, a randomized phase 3 study in early stage TNBC. (2018 · Journal of Clinical Oncology · 被引 36)
• Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance (2018 · Urologic Oncology Seminars and Original Investigations · 被引 36)
• MATTERHORN: Efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer—A randomized, double-blind, placebo-controlled, phase 3 study. (2021 · Journal of Clinical Oncology · 被引 31)
• Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing (2016 · Journal of the American College of Radiology · 被引 30)